Company / Accounts Receivable
Lantheus Holdings Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$358.6M
FY2025
5-year range
$89.3M / $358.6M
FY2021-FY2025
Trend
+11.6%
vs FY2024
Sector context
#55 of 138
Health Care
What the data says
At $359M, Lantheus Holdings's accounts receivable ranks #55 of 138 in the Health Care sector. Accounts Receivable has increased for 6 consecutive years, from $44M in FY2019 to $359M in FY2025.
Based on SEC 10-K filings.
$359M in FY2025 with a 5-year CAGR of +46.0%.
Improved from $284M to $359M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +18.9%
- 5-Year CAGR
- +46.0%
- 10-Year CAGR
- -
Sector benchmark
#55 of 138 in Health CareTop 40% of 138This company $358.6M Sector average $1.3B
▼
-72.8% below sector average
Key checks
Key Insights
- Lantheus Holdings's accounts receivable has grown for 6 consecutive years.
- 5-year CAGR of +46.0%, indicating consistent growth.
- In FY2025, accounts receivable increased 11.6% year-over-year.
- Ranks #55 out of 138 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $358.6M | +11.6% |
| FY2024 | $321.3M | +13.0% |
| FY2023 | $284.3M | +33.2% |
| FY2022 | $213.4M | +138.9% |
| FY2021 | $89.3M | +65.4% |
| FY2020 | $54.0M | +24.1% |
| FY2019 | $43.5M | -0.5% |
| FY2018 | $43.8M | +8.7% |
| FY2017 | $40.3M | +9.3% |
| FY2016 | $36.8M | -1.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026